nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2E1—Mitoxantrone—lymphatic system cancer	0.181	0.248	CbGbCtD
Trimethadione—CYP2C19—Teniposide—lymphatic system cancer	0.163	0.223	CbGbCtD
Trimethadione—CYP2C9—Teniposide—lymphatic system cancer	0.135	0.185	CbGbCtD
Trimethadione—CYP3A4—Cytarabine—lymphatic system cancer	0.0798	0.109	CbGbCtD
Trimethadione—CYP3A4—Teniposide—lymphatic system cancer	0.0786	0.108	CbGbCtD
Trimethadione—CYP3A4—Mitoxantrone—lymphatic system cancer	0.055	0.0753	CbGbCtD
Trimethadione—CYP3A4—Vincristine—lymphatic system cancer	0.0378	0.0518	CbGbCtD
Trimethadione—Tonic-clonic seizures—Carmustine—lymphatic system cancer	0.0112	0.0416	CcSEcCtD
Trimethadione—Non-Hodgkin's lymphoma—Mitoxantrone—lymphatic system cancer	0.00803	0.0298	CcSEcCtD
Trimethadione—Grand mal convulsion—Carmustine—lymphatic system cancer	0.00634	0.0235	CcSEcCtD
Trimethadione—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00434	0.0161	CcSEcCtD
Trimethadione—Lymphoma—Methotrexate—lymphatic system cancer	0.004	0.0149	CcSEcCtD
Trimethadione—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0038	0.0141	CcSEcCtD
Trimethadione—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00368	0.0136	CcSEcCtD
Trimethadione—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00366	0.0136	CcSEcCtD
Trimethadione—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00346	0.0128	CcSEcCtD
Trimethadione—Alopecia—Mechlorethamine—lymphatic system cancer	0.00323	0.012	CcSEcCtD
Trimethadione—Pancytopenia—Teniposide—lymphatic system cancer	0.0032	0.0119	CcSEcCtD
Trimethadione—Neutropenia—Teniposide—lymphatic system cancer	0.00315	0.0117	CcSEcCtD
Trimethadione—Vertigo—Mechlorethamine—lymphatic system cancer	0.00286	0.0106	CcSEcCtD
Trimethadione—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00285	0.0106	CcSEcCtD
Trimethadione—Pancytopenia—Fludarabine—lymphatic system cancer	0.00281	0.0104	CcSEcCtD
Trimethadione—Neutropenia—Fludarabine—lymphatic system cancer	0.00277	0.0103	CcSEcCtD
Trimethadione—Haemoglobin—Teniposide—lymphatic system cancer	0.00271	0.0101	CcSEcCtD
Trimethadione—Haemorrhage—Teniposide—lymphatic system cancer	0.0027	0.01	CcSEcCtD
Trimethadione—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00254	0.00944	CcSEcCtD
Trimethadione—Epistaxis—Fludarabine—lymphatic system cancer	0.00249	0.00924	CcSEcCtD
Trimethadione—Anorexia—Mechlorethamine—lymphatic system cancer	0.00248	0.00919	CcSEcCtD
Trimethadione—Alopecia—Teniposide—lymphatic system cancer	0.00238	0.00884	CcSEcCtD
Trimethadione—Haemoglobin—Fludarabine—lymphatic system cancer	0.00238	0.00884	CcSEcCtD
Trimethadione—Haemorrhage—Fludarabine—lymphatic system cancer	0.00237	0.00879	CcSEcCtD
Trimethadione—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00226	0.00838	CcSEcCtD
Trimethadione—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00224	0.00831	CcSEcCtD
Trimethadione—Diplopia—Carmustine—lymphatic system cancer	0.00219	0.00813	CcSEcCtD
Trimethadione—Leukopenia—Teniposide—lymphatic system cancer	0.0021	0.00779	CcSEcCtD
Trimethadione—Alopecia—Fludarabine—lymphatic system cancer	0.00209	0.00777	CcSEcCtD
Trimethadione—Pancytopenia—Bleomycin—lymphatic system cancer	0.00206	0.00765	CcSEcCtD
Trimethadione—Weight decreased—Bleomycin—lymphatic system cancer	0.00196	0.00729	CcSEcCtD
Trimethadione—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00191	0.0071	CcSEcCtD
Trimethadione—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00188	0.00696	CcSEcCtD
Trimethadione—Malaise—Fludarabine—lymphatic system cancer	0.00186	0.0069	CcSEcCtD
Trimethadione—Leukopenia—Fludarabine—lymphatic system cancer	0.00185	0.00685	CcSEcCtD
Trimethadione—Pruritus—Mechlorethamine—lymphatic system cancer	0.00184	0.00682	CcSEcCtD
Trimethadione—Anorexia—Teniposide—lymphatic system cancer	0.00183	0.00677	CcSEcCtD
Trimethadione—Pancytopenia—Carmustine—lymphatic system cancer	0.0018	0.00668	CcSEcCtD
Trimethadione—Neutropenia—Carmustine—lymphatic system cancer	0.00177	0.00657	CcSEcCtD
Trimethadione—Haemoglobin—Bleomycin—lymphatic system cancer	0.00175	0.00648	CcSEcCtD
Trimethadione—Haemorrhage—Bleomycin—lymphatic system cancer	0.00174	0.00645	CcSEcCtD
Trimethadione—Discomfort—Fludarabine—lymphatic system cancer	0.00174	0.00644	CcSEcCtD
Trimethadione—Pancytopenia—Vincristine—lymphatic system cancer	0.00172	0.00637	CcSEcCtD
Trimethadione—Neutropenia—Vincristine—lymphatic system cancer	0.00169	0.00627	CcSEcCtD
Trimethadione—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00167	0.00621	CcSEcCtD
Trimethadione—Decreased appetite—Teniposide—lymphatic system cancer	0.00167	0.00618	CcSEcCtD
Trimethadione—Vomiting—Mechlorethamine—lymphatic system cancer	0.00165	0.00613	CcSEcCtD
Trimethadione—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00165	0.00612	CcSEcCtD
Trimethadione—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00165	0.00611	CcSEcCtD
Trimethadione—Rash—Mechlorethamine—lymphatic system cancer	0.00164	0.00608	CcSEcCtD
Trimethadione—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00164	0.00607	CcSEcCtD
Trimethadione—Weight decreased—Vincristine—lymphatic system cancer	0.00164	0.00607	CcSEcCtD
Trimethadione—Anorexia—Fludarabine—lymphatic system cancer	0.0016	0.00595	CcSEcCtD
Trimethadione—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00159	0.00591	CcSEcCtD
Trimethadione—Feeling abnormal—Teniposide—lymphatic system cancer	0.00158	0.00586	CcSEcCtD
Trimethadione—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00157	0.00583	CcSEcCtD
Trimethadione—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00157	0.00581	CcSEcCtD
Trimethadione—Nausea—Mechlorethamine—lymphatic system cancer	0.00154	0.00573	CcSEcCtD
Trimethadione—Alopecia—Bleomycin—lymphatic system cancer	0.00154	0.0057	CcSEcCtD
Trimethadione—Haemoglobin—Carmustine—lymphatic system cancer	0.00152	0.00565	CcSEcCtD
Trimethadione—Haemorrhage—Carmustine—lymphatic system cancer	0.00152	0.00563	CcSEcCtD
Trimethadione—Abdominal pain—Teniposide—lymphatic system cancer	0.00151	0.00562	CcSEcCtD
Trimethadione—Paraesthesia—Fludarabine—lymphatic system cancer	0.00151	0.00561	CcSEcCtD
Trimethadione—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00147	0.00544	CcSEcCtD
Trimethadione—Decreased appetite—Fludarabine—lymphatic system cancer	0.00146	0.00543	CcSEcCtD
Trimethadione—Fatigue—Fludarabine—lymphatic system cancer	0.00145	0.00538	CcSEcCtD
Trimethadione—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00142	0.00526	CcSEcCtD
Trimethadione—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00141	0.00523	CcSEcCtD
Trimethadione—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00141	0.00523	CcSEcCtD
Trimethadione—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0014	0.00521	CcSEcCtD
Trimethadione—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00139	0.00515	CcSEcCtD
Trimethadione—Asthenia—Teniposide—lymphatic system cancer	0.00137	0.0051	CcSEcCtD
Trimethadione—Malaise—Bleomycin—lymphatic system cancer	0.00136	0.00506	CcSEcCtD
Trimethadione—Pruritus—Teniposide—lymphatic system cancer	0.00136	0.00503	CcSEcCtD
Trimethadione—Leukopenia—Bleomycin—lymphatic system cancer	0.00135	0.00502	CcSEcCtD
Trimethadione—Alopecia—Carmustine—lymphatic system cancer	0.00134	0.00497	CcSEcCtD
Trimethadione—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00131	0.00487	CcSEcCtD
Trimethadione—Alopecia—Vincristine—lymphatic system cancer	0.00128	0.00475	CcSEcCtD
Trimethadione—Discomfort—Bleomycin—lymphatic system cancer	0.00127	0.00472	CcSEcCtD
Trimethadione—Alopecia—Mitoxantrone—lymphatic system cancer	0.00125	0.00462	CcSEcCtD
Trimethadione—Vomiting—Teniposide—lymphatic system cancer	0.00122	0.00452	CcSEcCtD
Trimethadione—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00121	0.00448	CcSEcCtD
Trimethadione—Asthenia—Fludarabine—lymphatic system cancer	0.00121	0.00448	CcSEcCtD
Trimethadione—Rash—Teniposide—lymphatic system cancer	0.00121	0.00448	CcSEcCtD
Trimethadione—Dermatitis—Teniposide—lymphatic system cancer	0.00121	0.00448	CcSEcCtD
Trimethadione—Headache—Teniposide—lymphatic system cancer	0.0012	0.00445	CcSEcCtD
Trimethadione—Pruritus—Fludarabine—lymphatic system cancer	0.00119	0.00442	CcSEcCtD
Trimethadione—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00119	0.00442	CcSEcCtD
Trimethadione—Leukopenia—Carmustine—lymphatic system cancer	0.00118	0.00438	CcSEcCtD
Trimethadione—Anorexia—Bleomycin—lymphatic system cancer	0.00118	0.00436	CcSEcCtD
Trimethadione—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00114	0.00422	CcSEcCtD
Trimethadione—Nausea—Teniposide—lymphatic system cancer	0.00114	0.00422	CcSEcCtD
Trimethadione—Vertigo—Vincristine—lymphatic system cancer	0.00113	0.0042	CcSEcCtD
Trimethadione—Leukopenia—Vincristine—lymphatic system cancer	0.00113	0.00418	CcSEcCtD
Trimethadione—Paraesthesia—Bleomycin—lymphatic system cancer	0.00111	0.00411	CcSEcCtD
Trimethadione—Malaise—Mitoxantrone—lymphatic system cancer	0.00111	0.00411	CcSEcCtD
Trimethadione—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0011	0.00408	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00108	0.00399	CcSEcCtD
Trimethadione—Decreased appetite—Bleomycin—lymphatic system cancer	0.00107	0.00398	CcSEcCtD
Trimethadione—Vomiting—Fludarabine—lymphatic system cancer	0.00107	0.00397	CcSEcCtD
Trimethadione—Rash—Fludarabine—lymphatic system cancer	0.00106	0.00394	CcSEcCtD
Trimethadione—Dermatitis—Fludarabine—lymphatic system cancer	0.00106	0.00393	CcSEcCtD
Trimethadione—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00105	0.00391	CcSEcCtD
Trimethadione—Headache—Fludarabine—lymphatic system cancer	0.00105	0.00391	CcSEcCtD
Trimethadione—Discomfort—Mitoxantrone—lymphatic system cancer	0.00103	0.00383	CcSEcCtD
Trimethadione—Anorexia—Carmustine—lymphatic system cancer	0.00103	0.00381	CcSEcCtD
Trimethadione—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00102	0.00377	CcSEcCtD
Trimethadione—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00101	0.00374	CcSEcCtD
Trimethadione—Nausea—Fludarabine—lymphatic system cancer	0.001	0.00371	CcSEcCtD
Trimethadione—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000981	0.00364	CcSEcCtD
Trimethadione—Anorexia—Vincristine—lymphatic system cancer	0.00098	0.00364	CcSEcCtD
Trimethadione—Insomnia—Carmustine—lymphatic system cancer	0.000974	0.00362	CcSEcCtD
Trimethadione—Irritability—Methotrexate—lymphatic system cancer	0.000969	0.0036	CcSEcCtD
Trimethadione—Paraesthesia—Carmustine—lymphatic system cancer	0.000967	0.00359	CcSEcCtD
Trimethadione—Somnolence—Carmustine—lymphatic system cancer	0.000958	0.00355	CcSEcCtD
Trimethadione—Anorexia—Mitoxantrone—lymphatic system cancer	0.000955	0.00354	CcSEcCtD
Trimethadione—Decreased appetite—Carmustine—lymphatic system cancer	0.000937	0.00347	CcSEcCtD
Trimethadione—Insomnia—Vincristine—lymphatic system cancer	0.00093	0.00345	CcSEcCtD
Trimethadione—Paraesthesia—Vincristine—lymphatic system cancer	0.000924	0.00343	CcSEcCtD
Trimethadione—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000899	0.00334	CcSEcCtD
Trimethadione—Decreased appetite—Vincristine—lymphatic system cancer	0.000894	0.00332	CcSEcCtD
Trimethadione—Somnolence—Mitoxantrone—lymphatic system cancer	0.00089	0.0033	CcSEcCtD
Trimethadione—Feeling abnormal—Carmustine—lymphatic system cancer	0.000888	0.00329	CcSEcCtD
Trimethadione—Fatigue—Vincristine—lymphatic system cancer	0.000887	0.00329	CcSEcCtD
Trimethadione—Asthenia—Bleomycin—lymphatic system cancer	0.000886	0.00329	CcSEcCtD
Trimethadione—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000881	0.00327	CcSEcCtD
Trimethadione—Pruritus—Bleomycin—lymphatic system cancer	0.000873	0.00324	CcSEcCtD
Trimethadione—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000871	0.00323	CcSEcCtD
Trimethadione—Eosinophilia—Methotrexate—lymphatic system cancer	0.000869	0.00322	CcSEcCtD
Trimethadione—Fatigue—Mitoxantrone—lymphatic system cancer	0.000864	0.0032	CcSEcCtD
Trimethadione—Abdominal pain—Carmustine—lymphatic system cancer	0.000852	0.00316	CcSEcCtD
Trimethadione—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000841	0.00312	CcSEcCtD
Trimethadione—Pancytopenia—Methotrexate—lymphatic system cancer	0.000833	0.00309	CcSEcCtD
Trimethadione—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000825	0.00306	CcSEcCtD
Trimethadione—Neutropenia—Methotrexate—lymphatic system cancer	0.000821	0.00304	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000819	0.00304	CcSEcCtD
Trimethadione—Abdominal pain—Vincristine—lymphatic system cancer	0.000813	0.00302	CcSEcCtD
Trimethadione—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000792	0.00294	CcSEcCtD
Trimethadione—Vomiting—Bleomycin—lymphatic system cancer	0.000785	0.00291	CcSEcCtD
Trimethadione—Drowsiness—Methotrexate—lymphatic system cancer	0.000782	0.0029	CcSEcCtD
Trimethadione—Rash—Bleomycin—lymphatic system cancer	0.000778	0.00289	CcSEcCtD
Trimethadione—Dermatitis—Bleomycin—lymphatic system cancer	0.000778	0.00288	CcSEcCtD
Trimethadione—Asthenia—Carmustine—lymphatic system cancer	0.000773	0.00287	CcSEcCtD
Trimethadione—Epistaxis—Methotrexate—lymphatic system cancer	0.000738	0.00274	CcSEcCtD
Trimethadione—Asthenia—Vincristine—lymphatic system cancer	0.000738	0.00274	CcSEcCtD
Trimethadione—Nausea—Bleomycin—lymphatic system cancer	0.000733	0.00272	CcSEcCtD
Trimethadione—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00073	0.00271	CcSEcCtD
Trimethadione—Asthenia—Mitoxantrone—lymphatic system cancer	0.000719	0.00267	CcSEcCtD
Trimethadione—Haemoglobin—Methotrexate—lymphatic system cancer	0.000706	0.00262	CcSEcCtD
Trimethadione—Hepatitis—Methotrexate—lymphatic system cancer	0.000702	0.00261	CcSEcCtD
Trimethadione—Haemorrhage—Methotrexate—lymphatic system cancer	0.000702	0.00261	CcSEcCtD
Trimethadione—Vomiting—Carmustine—lymphatic system cancer	0.000685	0.00254	CcSEcCtD
Trimethadione—Rash—Carmustine—lymphatic system cancer	0.000679	0.00252	CcSEcCtD
Trimethadione—Dermatitis—Carmustine—lymphatic system cancer	0.000679	0.00252	CcSEcCtD
Trimethadione—Headache—Carmustine—lymphatic system cancer	0.000675	0.0025	CcSEcCtD
Trimethadione—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000664	0.00246	CcSEcCtD
Trimethadione—Vomiting—Vincristine—lymphatic system cancer	0.000654	0.00243	CcSEcCtD
Trimethadione—Rash—Vincristine—lymphatic system cancer	0.000648	0.00241	CcSEcCtD
Trimethadione—Dermatitis—Vincristine—lymphatic system cancer	0.000648	0.0024	CcSEcCtD
Trimethadione—Headache—Vincristine—lymphatic system cancer	0.000644	0.00239	CcSEcCtD
Trimethadione—Nausea—Carmustine—lymphatic system cancer	0.00064	0.00237	CcSEcCtD
Trimethadione—Vomiting—Mitoxantrone—lymphatic system cancer	0.000637	0.00236	CcSEcCtD
Trimethadione—Rash—Mitoxantrone—lymphatic system cancer	0.000632	0.00234	CcSEcCtD
Trimethadione—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000631	0.00234	CcSEcCtD
Trimethadione—Headache—Mitoxantrone—lymphatic system cancer	0.000627	0.00233	CcSEcCtD
Trimethadione—Alopecia—Methotrexate—lymphatic system cancer	0.000621	0.0023	CcSEcCtD
Trimethadione—Nausea—Vincristine—lymphatic system cancer	0.000611	0.00227	CcSEcCtD
Trimethadione—Nausea—Mitoxantrone—lymphatic system cancer	0.000595	0.00221	CcSEcCtD
Trimethadione—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000567	0.0021	CcSEcCtD
Trimethadione—Malaise—Methotrexate—lymphatic system cancer	0.000551	0.00205	CcSEcCtD
Trimethadione—Vertigo—Methotrexate—lymphatic system cancer	0.000549	0.00204	CcSEcCtD
Trimethadione—Leukopenia—Methotrexate—lymphatic system cancer	0.000547	0.00203	CcSEcCtD
Trimethadione—Discomfort—Methotrexate—lymphatic system cancer	0.000514	0.00191	CcSEcCtD
Trimethadione—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000489	0.00181	CcSEcCtD
Trimethadione—Anorexia—Methotrexate—lymphatic system cancer	0.000476	0.00176	CcSEcCtD
Trimethadione—Insomnia—Methotrexate—lymphatic system cancer	0.000451	0.00167	CcSEcCtD
Trimethadione—Paraesthesia—Methotrexate—lymphatic system cancer	0.000448	0.00166	CcSEcCtD
Trimethadione—Somnolence—Methotrexate—lymphatic system cancer	0.000444	0.00165	CcSEcCtD
Trimethadione—Decreased appetite—Methotrexate—lymphatic system cancer	0.000434	0.00161	CcSEcCtD
Trimethadione—Fatigue—Methotrexate—lymphatic system cancer	0.00043	0.0016	CcSEcCtD
Trimethadione—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000411	0.00153	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000408	0.00151	CcSEcCtD
Trimethadione—Abdominal pain—Methotrexate—lymphatic system cancer	0.000394	0.00146	CcSEcCtD
Trimethadione—Asthenia—Methotrexate—lymphatic system cancer	0.000358	0.00133	CcSEcCtD
Trimethadione—Pruritus—Methotrexate—lymphatic system cancer	0.000353	0.00131	CcSEcCtD
Trimethadione—Vomiting—Methotrexate—lymphatic system cancer	0.000317	0.00118	CcSEcCtD
Trimethadione—Rash—Methotrexate—lymphatic system cancer	0.000315	0.00117	CcSEcCtD
Trimethadione—Dermatitis—Methotrexate—lymphatic system cancer	0.000314	0.00117	CcSEcCtD
Trimethadione—Headache—Methotrexate—lymphatic system cancer	0.000313	0.00116	CcSEcCtD
Trimethadione—Nausea—Methotrexate—lymphatic system cancer	0.000296	0.0011	CcSEcCtD
